August 16, 2016
Okayama Taiho Pharmaceutical obtained approval on August 15 for an authorized generic (AG) version of Uzel tablets (calcium folinate), a folinic acid agent marketed by its parent company Taiho Pharmaceutical. The AG will be launched following its reimbursement listing in...read more